Loading: 100%
Endo International logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 4,894 (as per FY 2013)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker ENDPno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1706121824
datesClosing price (adj.)
13.10.20178.17
11.10.20178.98
04.10.20178.82
27.09.20179.04
20.09.20178.62
13.09.20179.28
06.09.20178.54
30.08.20178.55
23.08.20178.34
16.08.20178.70
09.08.20177.94
02.08.201710.54
26.07.201711.31
19.07.201712.08
12.07.201711.75
05.07.201711.39
27.06.201711.34
20.06.201711.04
13.06.201711.12
06.06.201712.54
30.05.201712.95
23.05.201712.89
16.05.201713.23
09.05.201712.82
02.05.201711.65
25.04.201711.00
18.04.201710.39
11.04.201710.76
04.04.201710.94
28.03.201710.74
21.03.201710.16
14.03.201710.22
07.03.201710.90
28.02.201713.65
21.02.201713.19
14.02.201712.65
07.02.201712.01
31.01.201712.24
24.01.201711.85
17.01.201713.07
10.01.201715.31
03.01.201717.47
27.12.201615.90
19.12.201616.03
12.12.201615.41
05.12.201615.87
28.11.201616.67
21.11.201617.10
14.11.201618.19
07.11.201615.68
31.10.201618.75
24.10.201620.81
17.10.201619.27
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
8.17n/a
Market Capitalisation
in million USD
942n/a
Enterprise Value
in million USD
4,214n/a
Common Shares Outstanding
as per Dec 31, 2013
115,354,393n/a
Preferred Shares Outstanding
as per Dec 31, 2013
n/a
Average Basic Shares Outstanding
TTM
113,295,000n/a
Average Diluted Shares Outstanding
TTM
113,295,000n/a
Index Membership
n/a
Business Summary
Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.
no data available
Key Financials & Ratios (all figures TTM as per Dec 31, 2013, million USD, full statements further below)
Profit & Loss
Revenues 2,617n/a
Gross Profit 1,577n/a
Operating Income -426n/a
EBITDA -170n/a
Net Profit -685n/a
Balance Sheet
Cash and Cash Equivalents 527n/a
Receivables 726n/a
Total Current Assets 2,855n/a
PP&E 372n/a
Total Assets 6,572n/a
Accounts Payable 263n/a
Current Debt 415n/a
Total Current Liabilities 1,697n/a
Long-Term Debt 3,324n/a
Total Liabilities 5,987n/a
Total Equity 585n/a
Cash Flow
Depreciation & Amortisation 256n/a
Change in Working Capital 60n/a
Operating Cash Flow 299n/a
Net Change in PP&E and Intangibles -95n/a
Investing Cash Flow -884n/a
Dividends Paid 0n/a
Financing Cash Flow 580n/a
Total Change in Cash -4n/a
Free Cash Flow -181n/a
Profitability Ratios
Gross Margin 60.3%n/a
Operating Margin -16.3%n/a
Net Profit Margin -24.2%n/a
Return on Equity -108.1%n/a
Return on Assets -9.6%n/a
Per Share Figures
Basic EPS -6.05n/a
Diluted EPS -6.05n/a
Sales per Share 23.10n/a
Book Value per Share 4.64n/a
FCF per Share -1.60n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio -1.35n/a
Price to Sales Ratio 0.35n/a
Price to Book Value 1.58n/a
Price to Free Cash Flow -5.12n/a
Valuation Metrics
EV/EBITDA -24.79n/a
EV/Sales 1.61n/a
Book to Market Value 0.62n/a
Other Ratios
Current Ratio 168.2%n/a
Liabilities to Equity Ratio 1,023.0%n/a
Debt to Assets Ratio 56.9%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13
Revenue
1,261
1,461
1,716
2,525
2,816
2,617
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-267
-375
-505
-948
-1,136
-1,040
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
993
1,086
1,211
1,577
1,680
1,577
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-606
-696
-746
-1,112
-2,220
-2,003
Selling, General & Administrative
-488
-535
-548
-784
-864
-849
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-110
-185
-145
-180
-219
-142
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
-8
24
-54
-148
-1,137
-1,011
Operating Income (Loss)
387
390
465
465
-540
-426
Non-Operating Income (Loss)
4
-34
-45
-147
-183
-123
Interest Expense, net
6
-38
-47
-148
-183
-174
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-2
3
2
1
0
51
Pretax Income (Loss), Adjusted
392
356
421
318
-723
-548
Abnormal Gains (Losses)
0
4
0
-12
-7
-11
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
4
0
-12
-7
-11
Pretax Income (Loss)
392
360
421
306
-730
-560
Income Tax (Expense) Benefit, net
-136
-93
-134
-112
36
24
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
255
266
287
194
-694
-536
Net Extraordinary Gains (Losses)
0
0
0
48
6
-97
Discontinued Operations
0
0
0
48
6
-97
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
255
266
287
242
-688
-632
Minority Interest
0
0
-28
-54
-52
-53
Net Income
255
266
259
188
-740
-685
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
255
266
259
188
-740
-685
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
734
466
548
530
527
Cash & Cash Equivalents
n/a
708
466
548
530
527
Short Term Investments
n/a
25
0
0
0
0
Accounts & Notes Receivable
n/a
324
548
733
651
726
Accounts Receivable, Net
n/a
324
548
733
651
726
Notes Receivable, Net
n/a
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
Inventories
n/a
85
179
262
345
374
Raw Materials
n/a
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
Other Short Term Assets
n/a
138
167
245
688
1,228
Prepaid Expenses
n/a
17
23
30
22
39
Derivative & Hedging Assets
n/a
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
331
160
Deferred Tax Assets
n/a
90
141
215
299
258
Income Taxes Receivable
n/a
14
3
0
36
0
Discontinued Operations
n/a
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
17
0
0
0
770
Total Current Assets
n/a
1,281
1,360
1,788
2,213
2,855
Property, Plant & Equipment, Net
n/a
48
215
298
359
372
Property, Plant & Equipment
n/a
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
Long Term Investments & Receivables
n/a
212
24
19
2
3
Long Term Investments
n/a
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
Other Long Term Assets
n/a
949
2,314
5,188
3,994
3,342
Intangible Assets
n/a
0
0
0
0
0
Goodwill
n/a
303
715
2,558
1,854
1,373
Other Intangible Assets
n/a
610
1,532
2,504
2,047
1,873
Prepaid Expense
n/a
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
36
67
125
94
97
Total Noncurrent Assets
n/a
1,208
2,553
5,504
4,355
3,717
Total Assets
n/a
2,489
3,912
7,293
6,569
6,572
Liabilities and owners' equity
Payables & Accruals
n/a
472 472180000
711 710835000
1,029 1028588000
1,554 1554261000
1,246 1246294000
Accounts Payable
n/a
176 176076000
241 241114000
260 260385000
412 412065000
263 263241000
Accrued Taxes
n/a
9 9498000
0 0
35 35372000
0 0
3 3089000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
287 286606000
470 469721000
733 732831000
1,142 1142196000
980 979964000
Short Term Debt
n/a
0 0
25 24993000
88 88265000
132 132156000
415 414929000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
5 4925000
65 64771000
35 35449000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
5 4925000
65 64771000
35 35449000
Total Current Liabilities
n/a
472 472180000
736 735828000
1,122 1121778000
1,751 1751188000
1,697 1696672000
Long Term Debt
n/a
323 322534000
1,046 1045801000
3,424 3424329000
3,035 3035031000
3,324 3323844000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
197 196678000
327 327431000
707 706885000
649 649134000
966 966124000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
49 49180000
217 217334000
618 617677000
497 496778000
311 310764000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
147 147498000
110 110097000
89 89208000
152 152356000
655 655360000
Total Noncurrent Liabilities
n/a
519 519212000
1,373 1373232000
4,131 4131214000
3,684 3684165000
4,290 4289968000
Total Liabilities
n/a
991 991392000
2,109 2109060000
5,253 5252992000
5,435 5435353000
5,987 5986640000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
819 818817000
862 862245000
954 953708000
1,037 1036515000
1,168 1167819000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-425 -424816000
-484 -483790000
-518 -518492000
-768 -768430000
-763 -763120000
Retained Earnings
n/a
1,105 1105291000
1,364 1364297000
1,552 1551910000
812 811573000
126 126234000
Other Equity
n/a
-2 -1881000
-1 -1161000
-9 -9436000
-7 -6802000
-5 -4915000
Equity Before Minority Interest
n/a
1,497 1497411000
1,742 1741591000
1,978 1977690000
1,073 1072856000
526 526018000
Minority Interest
n/a
0 0
62 61738000
62 61901000
60 60350000
59 59198000
Total Equity
n/a
1,497 1497411000
1,803 1803329000
2,040 2039591000
1,133 1133206000
585 585216000
Total Liabilities & Equity
n/a
2,489 2488803000
3,912 3912389000
7,293 7292583000
6,569 6568559000
6,572 6571856000
Remarks restated on n/a restated on Feb 28, 2011 n/a restated on Feb 29, 2012 n/a restated on Mar 1, 2013 n/a restated on Mar 3, 2014 n/a restated on Mar 3, 2014 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '08FY '09FY '10FY '11FY '12FY '13
Net Income/Starting Line
255
266
287
242
-688
-632
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
46
80
108
237
286
256
Non-Cash Items
50
-64
15
123
682
616
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
4
12
44
100
454
60
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
356
295
454
702
734
299
Change in Fixed Assets & Intangibles
-14
-12
-20
-58
-98
-95
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
313
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-15
-250
-1,105
-2,380
-3
5
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
-104
17
228
64
13
-794
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
180
-246
-896
-2,374
-88
-884
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
262
-121
318
1,890
-364
543
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-423
8
-38
-6
-231
102
Increase in Capital Stock
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
Other Financing Activities
51
-4
-79
-131
-51
-66
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
-110
-117
200
1,753
-646
580
Net Cash Before Disc. Operations and FX
425
-67
-242
81
0
-6
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
425
-67
-242
81
0
-6
Effect of Foreign Exchange Rates
0
0
0
1
0
2
Net Changes in Cash
425
-67
-242
81
0
-4
Remarks
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Mar 1, 2013 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
restated on Mar 3, 2014 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo